Skip to main content

Day: March 14, 2024

iSpecimen Reports Full Year 2023 Results

LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2023. “Throughout 2023, we advanced our objective to reach profitability, focusing on right-sizing our business and implementing new operational efficiencies,” said Tracy Curley, CEO of iSpecimen. “As we strive to become cash flow positive, we are focusing our efforts on growing topline revenues through our core business segments by capitalizing on our Next Day Quotes program, where we continue to see increased traction. We have also invested in new marketing initiatives and...

Continue reading

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company received a letter on March 13, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”). As indicated in the letter, Nasdaq determined that for 10 consecutive business days, the closing bid price of the Company’s common stock was at or above $1.00 per share. Accordingly, the Company has regained compliance with the Minimum Bid Price Requirement. About 180 Life Sciences Corp. 180 Life Sciences Corp. is a clinical stage biotechnology company focused on the development of therapeutics...

Continue reading

Cheer Holding Reports Full Year 2023 Financial Results

BEIJING, March 14, 2024 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced its financial results for the full year ended December 31, 2023. Full Year 2023 Operating Highlights Total Downloads of CHEERS Apps was approximately 474 million as of December 31, 2023, compared to approximately 377 million as of December 31, 2022. Specifically: CHEERS VideoMonthly Active Users of CHEERS Video increased by 5% to approximately 50.1 million. Daily Time Spent on CHEERS Video was 59 minutes during the commercial year of 2023.CHEERS e-MallMonthly Active Users of CHEERS e-Mall increased by 71% to approximately 6.5 million. Repurchase Rate on CHEERS e-Mall was 39.6% during the...

Continue reading

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

– Presented initial data from Phase 1 ELiPSE-1 Trial of CNTY-101 in relapsed/refractory B-cell lymphomas demonstrating a favorable tolerability profile, early clinical activity and indication that Allo-Evasion™ may support a multi-dosing regimen without the need for continued lymphodepletion – – Received investigational new drug (IND) clearance for CNTY-101 for the treatment of systemic lupus erythematosus (SLE); On track to initiate Phase 1 CALiPSO-1 clinical trial in the first half of 2024 – – Six posters to be presented at upcoming AACR Annual Meeting 2024 highlighting Century’s end-to-end cell therapy capabilities including expertise across iPSC reprogramming, gene editing, protein engineering, Allo-Evasion™ technology and computational biology – – Ended 2023 with cash, cash...

Continue reading

Alarum Announces Record of $1.7 Million Net Profit and $2.2 Million Adjusted EBITDA in the Fourth Quarter of 2023

Revenue Continues to Set Records; $7.1 million in the fourth quarter and over $26.5 million for full year 2023 NetNut’s revenues surged 150% both for the fourth quarter of 2023 and the entire year compared to the equivalent periods in 2022 – the annual revenue amounted to more than $21 millionTEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and data collection solutions, today announced record financial results for the three months and full year periods, ended December 31, 2023.  Key highlights for the three months and year ended December 31, 2023:Net Retention Rates (NRR)1– Starting from 2024, the Company plans to update on a quarterly basis its customer retention (NRR). NetNut Ltd.’s (“NetNut”) NRRs were...

Continue reading

Guardian Capital Announces March 2024 Cash Distributions for Guardian Capital ETFs

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending March 31, 2024, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on March 28, 2024 to unitholders of record on March 22, 2024. The ex-dividend date in each case is anticipated to be March 21, 2024, with the exception of Guardian Ultra-Short Canadian T-Bill Fund and Guardian Ultra-Short U.S. T-Bill Fund which are money market funds and which are anticipated to have an ex-dividend date of March 22, 2024.Guardian Capital ETFs Series of ETF Units DistributionFrequency TradingSymbol Exchange Distribution Amount(per ETF Unit)Guardian Directed Equity Path Portfolio Hedged ETF Units Monthly GDEP TSX CAD$0.0770Guardian...

Continue reading

Invesco Ltd: Form 8.3 – Ageas SA/NV_OPD

FORM 8.3 OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Full name of discloser: Invesco Ltd.(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Ageas SA/NV(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position held/dealing undertaken:         For an opening position...

Continue reading

cBrain releases first F2 standard module for government AI

  Company Announcement no. 04/2024 cBrain releases first F2 standard module for government AI   Copenhagen, March 14, 2024   In close collaboration with Danish government authorities, cBrain (NASDAQ: CBRAIN) has designed and developed a new F2 standard module for government Artificial Intelligence (AI). The new module is called F2 AI Assistant. The release of the F2 AI Assistant module represents a milestone for cBrain, which strongly supports cBrains growth plan. It extends the F2 digital platform and initiates a new product line of AI-based software modules and extensions. F2 AI Assistant is designed for government and operates on premise. Fully integrated with F2 and delivered as a standard extension module, F2 AI Assistant offers government organizations a fast track to leverage AI while eliminating numerous issues related to personal...

Continue reading

Aveanna Healthcare Holdings Announces Fourth Quarter 2023 Financial Results and 2024 Outlook

Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior yearGross margin increased 15.3% to $148.4 million, compared to Q4 2022Fourth Quarter Net loss was $25.7 million, compared to net loss of $237.8 million in the comparable prior year periodAdjusted EBITDA was $38.7 million, a 30.4% increase as compared to the prior year quarterExpect Full Year 2024 Revenue between $1,960 million and $1,980 million and Adjusted EBITDA between $146 million and $150 millionATLANTA, March 14, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period and fiscal year ended December 30, 2023. Jeff Shaner, Chief Executive Officer,...

Continue reading

PyroGenesis Announces $450K Contract for the Sale of a Plasma Torch/Furnace System for Advanced Green Cement Development

MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce the signing of a contract with a U.S. structural materials entity engaged in the development of advanced cement materials. The first phase of the contract is approximately CDN$450,000 with the potential for future phases. Funded in part by the U.S. Department of Energy (“DOE”), the name of the client will remain anonymous for confidentiality reasons. “The cement industry is one we have been targeting, as it is one of the highest-emitting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.